Noninvasive strategies in COVID-19: epistemology, randomised trials, guidelines, physiology

Martin J. Tobin, Amal Jubran, Franco Laghi

Source: Eur Respir J, 57 (2) 2004247; 10.1183/13993003.04247-2020
Journal Issue: February

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Martin J. Tobin, Amal Jubran, Franco Laghi. Noninvasive strategies in COVID-19: epistemology, randomised trials, guidelines, physiology. Eur Respir J, 57 (2) 2004247; 10.1183/13993003.04247-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of response
Source: Eur Respir Rev 2014; 23: 367-378
Year: 2014

The future of translational lung cancer research: from classical randomised controlled trials to innovative platform trials
Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer
Year: 2018

Efficacy of acupuncture in asthma: systematic review and meta-analysis of published data from 11 randomised controlled trials
Source: Eur Respir J 2002; 20: 846-852
Year: 2002

Comprehensive self management and routine monitoring in chronic obstructive pulmonary disease patients in general practice: Randomised controlled trial
Source: Annual Congress 2013 –The best posters in chronic care
Year: 2013

Clinical effectiveness of self-management of asthma in general practice: a randomized controlled trial
Source: Eur Respir J 2001; 18: Suppl. 33, 518s
Year: 2001

A non-interventional observational trial to study the COPD treatment choices in routine clinical practice in Bulgaria
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016

No gender-related bias in COPD diagnosis and treatment in Sweden: a randomised, controlled, case-based trial
Source: ERJ Open Res, 6 (4) 00342-2020; 10.1183/23120541.00342-2020
Year: 2020

Large trials, new knowledge: the changing face of COPD management
Source: Eur Respir J 2015; 45: 1692-1703
Year: 2015

An interactive web-based pulmonary rehabilitation programme: A randomised controlled feasibility trial
Source: International Congress 2016 – Best abstracts in physical activity and telemedicine
Year: 2016

Clinical trial landscape for M/XDR-TB: current evidence and future perspectives
Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis
Year: 2019

Effect of reflexology, homeopathy, and traditional medical treatment in asthma: A randomised, controlled, parallel-group trial
Source: Annual Congress 2010 - Questionnaires use and psychological aspects in asthma
Year: 2010

Establishing new treatments: the role of RCTs
Source: Virtual Congress 2020 – Tuberculosis: learning from the WHO global health emergencies
Year: 2020

TargetCOPD: A pragmatic randomised controlled trial of targeted case finding for COPD versus routine practice in primary care
Source: International Congress 2015 – Diagnosing and management of COPD in primary care
Year: 2015

Thoracic oncology, this journal club will explore a major randomised trial in mesothelioma treatment, implications for practice and the strengths and weaknesses of the study in the context of the published data
Source: Journal Club 2022
Year: 2022

Does pulmonary rehabilitation work in clinical practice? A review on selection and dropout in randomised controlled trials on pulmonary rehabilitation
Source: Annual Congress 2010 - Outcomes and predictors of the sucess of pulmonary rehabilitation in chronic respiratory disease
Year: 2010

Late Breaking Abstract - Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof of concept clinical trial
Source: Virtual Congress 2021 – Highlights in COVID-19 diagnosis and treatment
Year: 2021

Cost-effectiveness of self-management in asthmatics: a 1-yr follow-up randomized, controlled trial
Source: Eur Respir J 2001; 17: 206-213
Year: 2001

Negative clinical trials in sarcoidosis: failed therapies or flawed study design?
Source: Eur Respir J 2014; 44: 1123-1126
Year: 2014